Ignite Creation Date:
2024-05-06 @ 2:01 AM
Last Modification Date:
2024-10-26 @ 11:12 AM
Study NCT ID:
NCT01950273
Status:
COMPLETED
Last Update Posted:
2018-09-05
First Post:
2013-09-23
Brief Title:
Pharmacokinetics and Pharmacodynamics of BI 695500 vs Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma Follicular |
Keywords: